Comparison of Transperineal Mapping Biopsy Results with Whole-Mount Radical Prostatectomy Pathology in Patients with Localized Prostate Cancer

Table 1

Patient characteristics at initial TRUS-guided biopsy (𝑁=17).

PSA (ng/mL), median (IQR)	5.6 (4.1–7.0)
Clinical stage, 𝑛 (%)
T1c	13 (76)
T2a	2 (12)
No cancer	2 (12)
Number of cores taken at TRUS biopsy, 𝑛 (%)
6	1 (6)
10–12	10 (59)
>12	6 (35)
Number of positive cores, 𝑛 (%)
0	2 (12)
1	13 (76)
2	2 (12)
Length of cancer in positive cores (mm),; median (IQR)	1.5 (0.7–2.0)
% of positive cores, 𝑛 (%)
0%	2 (12)
1–5%	11 (65)
6–10%	3 (18)
>10%	1 (6)
Biopsy Gleason score, 𝑛 (%)
2+3	1 (6)
6	11 (65)
7 (3+4)	3 (18)
No cancer	2 (12)
Laterality
Right	8 (47)
Left	6 (35)
Bilateral	1 (6)
No cancer	2 (12)
Time between TRUS biopsy and prostatectomy (months), median (IQR)	4 (3–6)